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ABSTRACT 
The cellular response to DNA damage (DDR) that causes replication collapse and/or DNA 
double strand breaks, is characterised by a massive change in the post-translational 
modifications (PTM) of hundreds of proteins involved in the detection and repair of DNA 
damage, and the communication of the state of damage to the cellular systems that regulate 
replication and cell division. A substantial proportion of these PTMs involve targeted 
phosphorylation, which among other effects, promotes the formation of multiprotein 
complexes through the specific binding of phosphorylated motifs on one protein, by 
specialised domains on other proteins. Understanding the nature of these phosphorylation 
mediated interactions allows definition of the pathways and networks that coordinate the 
DDR, and helps identify new targets for therapeutic intervention that may be of benefit in the 
treatment of cancer, where DDR plays a key role. In this review we summarise the present 
understanding of how phosphorylated motifs are recognised by BRCT domains, which occur 
in many DDR proteins. We particularly focus on TOPBP1 – a multi-BRCT domain scaffold 














1.  INTRODUCTION 
The DNA Damage Response (DDR) is an extraordinary, transient reconfiguring of cellular 
behaviour, driven by a massive cascade of post-translational events (primarily 
phosphorylation) downstream of DNA damage detection. Even in a simple model organism 
such as budding yeast – S. cerevisiae – exposure to DNA damaging agents results in 
substantially increased phosphorylation of more than 1500 sites across hundreds of proteins 
[1]. The mechanistic role of only a tiny fraction of these phosphorylation events has been 
studied. 
Here, we review the present understanding of how this phosphorylation facilitates assembly 
of the large multiprotein complexes that allow cells to orchestrate their response to DNA 
damage and to maintain genome stability. In particular we focus on the function of BRCA1 
C-terminus (BRCT) domains in recognition of phosphorylated motifs in DDR proteins, and 
the role of DNA topoisomerase II binding protein 1 (TOPBP1) – a large scaffold protein 
containing multiple BRCT domains - that plays key roles in regulating replication, DNA break 
repair and mitosis. 
 
2. γ-H2AX and BRCT domains 
Since its discovery [2], phosphorylation of the most C-terminal serine residue (Ser 139) in 
the histone H2A variant H2AX has become the definitive biomarker for the presence of DNA 
double-strand breaks (DSBs) in mammalian cells [3]. Comparable phosphorylations of 
closely related C-terminal motifs are also observed in both of the yeast species commonly 
used in genome stability studies, Saccharomyces cerevisiae [4] and Schizosaccharomyces 
pombe [5] but here the phosphorylation occurs on the normal histone H2A isoform rather 
than a specialised variant. 
It was recognised early on that foci of phosphorylated H2AX (known as γH2AX) observed by 
immunohistochemistry, within the nuclei of cells subjected to genotoxic insult, co-localised 
with foci of important DNA repair factors such as RAD50, RAD51 and BRCA1 [6]. Based on 
these observations, it was suggested that the γH2AX modification might function to facilitate 
decompaction of chromatin, thereby contributing to the indirect recruitment of downstream 
factors by providing access to the site of damage. However, subsequent studies 
demonstrated that γH2AX is a direct participant in recruitment of repair factors, and interacts 
directly with MDC1 [7]; via specific binding of its C-terminal tetrapeptide incorporating 











and the earlier demonstrations of phosphorylation-dependent interactions of BRCA1 and 
PTIP [9, 10], highlighted the key role played by BRCT domains in mediating interactions 
between proteins involved in the DNA damage response.  
The high affinity interaction between γH2AX and the tandem BRCT domain pair (BRCT2) 
module at the C-terminus of MDC1 (0.4 μM, in vitro) [11] is a key step in the amplification 
and spreading of the γH2AX signal via recruitment of MRN and ATM, which in metazoan 
cells also facilitates recruitment of 53BP1 and the associated Shieldin complex to DNA 
double strand breaks, through ubiquitylation of histone H2A [12, 13]. Although no MDC1 
homologue is evident in S.cerevisiae, Mdb1 in S.pombe has a similar molecular architecture 
and shares the ability of MDC1 to interact with the equivalent γH2A modification via its C-
terminal BRCT2 module [14] (FIGURE 1B). However, unlike MDC1, which is essential for 
genomic stability, Mdb1 appears to be largely dispensible. 
The central role of MDC1 in metazoan DSB repair, has tended to dominate thinking about 
the function of γH2AX as a DNA damage signal, and understanding of its recognition by 
other factors has been less well explored. 
 
2.1 C-terminal BRCT2 modules 
A C-terminal BRCT2 module also occurs at the C-terminus of S.cerevisiae Rad9p (not to be 
confused with S.pombe and metazoan RAD9 which is a part of the 9-1-1 complex), S.pombe 
Crb2, and metazoan 53BP1. The BRCT2 modules in both Rad9p and Crb2 have been 
shown to interact with γH2A, and mutational disruption of this interaction impacts DNA 
damage responses [5, 15]. Structural analysis of the Crb2-BRCT2 module revealed a similar 
mode of interaction with the C-terminal phosphopeptide motif of γH2A as that seen in the 
interaction of MDC1-BRCT2 with MDC1, allowing the identification of key features in the 
BRCT2 module that mediate the specificity for the phosphorylated serine and carboxyl-
terminus [16]. Critical to the ability of BRCT domains to recognise the phosphorylated status 
of ligand peptides, are a triplet of amino acids (Ser548, Arg558 and Lys619 in Crb2) which 
make multiple hydrogen binding and charge-neutralising interactions with the negatively-
charged phosphate group of the phosphorylated peptide (FIGURE 1C). The presence of this 
phospho-binding (PB) triplet motif is fully diagnostic of the ability of a BRCT domain to 
interact with phosphorylated sites on ligand proteins. 
Despite the strong conservation of these features in 53BP1, a number of studies suggested 











function in DSB repair [17, 18]. However, subsequent structural and biochemical studies 
showed a direct and specific interaction of 53BP1-BRCT2 with γH2AX (FIGURE 1D), and 
demonstrated DNA repair defects when this interaction was disrupted in cells, that 
particularly impacted on the late-phase repair of persistent DSBs in heterochromatin and 
other highly condensed chromatin settings [11, 19]. 
Metazoan PTIP, S.cerevisiae Rtt107 and S.pombe Brc1 have also been shown to bind to 
γH2AX in a similar manner to MDC1 and 53BP1 [20] (FIGURE 1E), or γH2A in the case of 
Rtt107 [21] and Brc1 [22]. Of the other metazoan proteins that contain a C-terminal BRCT 
domain, Microcephalin (MCPH1) is the only other known to be a γH2AX interacting partner 
[23] and it has no known equivalent in yeast. Despite the PB-motif in the C-terminal BRCT2 
module containing an Asn in the place of the conserved Lys residue it is able to coordinate 
phosphorylated ligands and a crystal structure of the complex demonstrated the expected 
conformation [24] (FIGURE 1F).  
The structure of the C-terminal BRCT2 module of MCPH1 bound to a H2AX peptide where 
Tyr-142 is phosphorylated in addition to Ser-139, has also been determined [25] (FIGURE 
1G). Tyr-142 is constitutively phosphorylated by WTSF and has been shown to modulate the 
DNA damage response, being gradually dephosphorylated by the Eyes Absent 
phosphatases [26] as it progresses [27], while also being responsible for the recruitment of 
pro-apoptotic factors [28]. MCPH1 can clearly accommodate the phosphorylated tyrosine 
modification, and while it is currently unclear what affect it would have on the interaction with 
PTIP, it has been demonstrated that both MDC1 [29] and 53BP1 [11] discriminate against 
binding to a pS139 pY142 H2AX peptide. A number of mass spectrometry studies have 
been unable to identify the pY142 modification in vivo [30, 31], creating doubt about how 
widespread the existence of this marker is, however it is clear that where found it would 
enable differentiation of which proteins were able to bind to γH2AX. 
While the C-terminal BRCT2 modules of MDC1, 53BP1, PTIP and MCPH1 all appear to be 
specifically adapted for unique recognition of the highly acidic terminal phosphorylated-motif 
of γH2AX, the structurally homologous BRCT2 module at the C-terminus of BRCA1 is able 
interact more promiscuously with phosphorylation sites embedded within their ligand 
proteins’ amino acid sequence, that incorporate a pSer-X-X-Phe motif [32]. Structurally 
characterised ligands for BRCA1-BRCT2 include other DNA repair factors such as 
FANCJ/BACH1 [33, 34] (FIGURE 1H), BARD1 [35], CtIP [36], ATRIP [37], BRAT1/BAAT1 
[37] and Abraxas [38], but also a metabolic enzyme Acetyl-CoA Carboxylase [39]. Other 












2.2 MCPH1 and PTIP – alternative BRCT domain arrangements  
In addition to the C-terminal pair, MCPH1 contains an additional singleton BRCT domain at 
its N-terminus that lacks the PB-motif residues [40]. This BRCT domain has been shown to 
interact in a non-phosphorylation dependent manner with a number of other proteins 
including SET [41] and the BAF170 component of the SWI/SNF chromatin-remodelling 
complex [42]. Although the exact structural basis of the interactions made by this singleton 
BRCT domain remain to be determined, mutations made in a hydrophobic pocket located in 
the corresponding position to the phosphate binding pocket, prevent the ability of MCPH1 to 
rescue phenotypes caused by a MCPH1 deletion [40], demonstrating that BRCT domains 
have evolved to be capable of distinct interaction modes. 
PTIP and the related yeast proteins Brc1 and Rtt1107 each consist of a tandem 
arrangement of three BRCT-pairs including a C-terminal BRCT2 module that interacts with 
γH2AX (BRCTs 5 and 6).  
In PTIP, both other BRCT pairs contain a single PB motif, however these are found in the 
second BRCT of each module (BRCTs 2 and 4) distinguishing them from the canonical 
BRCT2 arrangement (FIGURE 2A). While there are no structures demonstrating 
phosphorylation dependent interactions, a number of candidates have been identified in the 
literature. A region corresponding to BRCTs 3,4,5 and 6 of PTIP is required for focus 
formation [43] and when Serine-25 in 53BP1 is phosphorylated it is able to interact with PTIP 
in a way that requires both C-terminal pairs of BRCT domains in PTIP [44]. Close 
examination of the data in these papers suggests some recruitment for a construct without 
the C-terminal pair, but all four being required for a robust recruitment or interaction, placing 
Ser-25 of 53BP1 as a candidate for interaction with BRCT4 of PTIP. Artemis has been 
clearly identified as interacting with BRCT2 of PTIP promoting the use of the NHEJ repair 
pathway over HR [45]. 
For the two yeast proteins, the only other PB-motif is found in BRCT4. While no ligands have 
yet been identified for Brc1, pThr-80 of histone H4 has been shown to interact with BRCT 4 
of Rtt107 with the interaction being important for inactivation of the signalling cascades that 
follow the DNA damage checkpoint [46].  
The N-terminal BRCT-pair of Rtt107 lacks a conserved PB motif, however it has been shown 
to form an unusual ‘tetra-BRCT’ arrangement, involving BRCTs 1, 2, 3 and 4, which is able 











a region located between the binding pockets of BRCTs 2 and 4 [47]. The arrangement of 
this module is such that a channel exists between BRCTs 1 and 4 that could accommodate 
a phosphorylated motif binding into the PB motif of BRCT4 (FIGURE 2B), although given the 
proximity to the binding site for the phosphorylation independent interactions seen in the 
crystal structures, the two types of interaction would likely occlude each other. In fact, in the 
Nse6 bound structure, serine-18 of the peptide, which is followed by a glutamine making it a 
consensus Mec1/Tel1 site, sits tantalisingly close to the PB in BRCT 4 (FIGURE 2C) and it 
would be interesting to see if the interaction is enhanced by its phosphorylation. The overall 
architecture of PTIP is different to the yeasts due to a large insertion, including a polyQ tract, 
between BRCT domains 2 and 3 and therefore it is unclear as to whether it would be able to 
form the same tetra-BRCT arrangement. 
Detailed molecular dissection of PTIP interactions is in its infancy and clearly more work is 
required to enable an understanding of the different phosphorylation dependent complexes it 
scaffolds. 
 
3. TOPBP1/Rad4/Dpb11 – an abundance of BRCTs 
Although the BRCT domain is named in recognition of its presence at the C-terminus of 
BRCA1 [48], its occurrence as a repeated functional module was first noted in the product of 
the S.pombe radiation-sensitivity gene Rad4 [49-51], which contains four copies arranged as 
two tandem pairs. A similar architecture is possessed by the S.cerevisiae homologue Dpb11 
[52]. Cloning of the human orthologue of Rad4 and Dpb11 - TOPBP1 - revealed a more 
elaborate architecture in which eight BRCT domains could be identified [53]. Comparison of 
the mammalian and yeast sequences suggest that the larger structure of TOPBP1 is not a 
simple duplication of the smaller yeast arrangements, but instead results from a complex 
pattern of evolutionary modifications, with the insertion of a singleton BRCT domain, BRCT3, 
between the tandem pairs that are homologous to those of the yeast proteins, and the 
addition of a further singleton, BRCT6, and an additional tandem pair at the C-terminus [54]. 
Structural analysis of this C-terminal tandem pair BRCT7,8 of human TOPBP1 [55], revealed 
a very similar architecture to the ‘canonical’ BRCT2 structures in MDC1, 53BP1, BRCA1 and 
their yeast homologues, and TOPBP1-BRCT7,8 shares the ability of BRCA1-BRCT2 to 
interact with the DNA helicase FANCJ/BACH1 in a phosphorylation-dependent manner, 











Structural analysis of the N-terminal BRCT repeats of TOPBP1 and Rad4, revealed a very 
different arrangement of the BRCT domains to that seen in the canonical BRCT2 structures 
[57-59]. Most surprising was the presence of an additional BRCT domain – designated 
BRCT0 – at the N-terminus of TOPBP1, which is absent from the yeast Rad4. Unlike the 
canonical BRCT2 modules in which only the first domain carries the PB-motif and the two 
BRCT domains combine to offer a single phosphopeptide binding site, the PB-motif was 
present in both BRCT1 and BRCT2 in TOPBP1/Rad4, suggesting that they might each be 
able to bind a phosphopeptide ligand independently. BRCT0 which is only present in 
TOPBP1 lacks the PB-motif and its biological function remains obscure. The central BRCT-
pairs of TOPBP1 (BRCT4,5) and Rad4 (BRCT3,4) have an arrangement of their component  
domains that is distinct from both the canonical modules and the TOPBP1/Rad4 N-terminal 
modules [59, 60]. Like the canonical BRCT2 modules, only one BRCT domain contains a 
PB-motif, but in this case, it is in the second domain – BRCT5 in TOPBP1, BRCT4 in Rad4. 
Neither of the singleton BRCT domains in TOPBP1 have PB-motifs. 
 
3.1 Scaffolding enzymes 
A range of ligand proteins for TOPBP1 and/or its orthologues, have been identified, whose 
interactions are mediated through binding of a phosphorylation site (or sites) on the ligand 
protein, to one or more of the PB-motif containing BRCT domains of TOPBP1 (FIGURE 3A-
C). Several of these are ATP-dependent DNA helicases whose ability to interact with 
TOPBP1 is critical to their biological function: the chromatin remodeller SMARCAD1 and its 
S.cerevisiae orthologue FUN30, interact with the N-terminal BRCT1,2 module of TOPBP1 
and Dbp11 respectively [61]; the RECQ-family helicase BLM interacts with the BRCT4,5 
module of TOPBP1 [62, 63]; and FANCJ/BACH1, a helicase involved in alleviation of 
replication stress, binds to the C-terminal BRCT7,8 module [55, 56]. It is currently unclear 
whether association with TOPBP1 plays a direct mechanistic role in the function of these 
helicases, or just serves to localise them to their sites of action. 
TOPBP1 also interacts with both of the type-II DNA topoisomerases, TOP2A [64] and 
TOP2B [53] – the latter of which gives TOPBP1 its name. In both cases a C-terminal 
segment of TOPBP1 including BRCT6 and the canonical phosphopeptide-binding BRCT7,8 
module is required for the interaction, and at least for TOP2B there is indirect evidence that 
the interaction is mediated by phosphorylation, although the site (or sites) involved have not 
been identified. As with the TOPBP1 helicases, the main function of the interaction is to 











(UFBs) in the case of TOP2A – and abrogation of the interaction results in a failure to 
resolve these structures [64]. Interestingly, the same study identified a requirement for the 
PB-motif of TOPBP1-BRCT5 to recruit TOPBP1 itself to UFBs, implying a requirement for 
interaction with a phosphorylated motif of a protein earlier in the recruitment cascade. 
However, none of the known BRCT5 phospho-dependent interactors fulfilled this role, and 
the identity of this protein remains unknown. 
Interaction with PARP1 is believed to be mediated through BRCT6 of TOPBP1 [65]. It was 
initially suggested this may be achieved through a conserved PAR binding motif in BRCT6, 
however structural elucidation revealed the motif to be buried, ruling out that interaction 
mode [66]. The use of in vitro translated proteins in this study, along with the lack of the PB-
motif residues in BRCT6, would suggest the interaction is unlikely to be phosphorylation 
dependent. 
Recently, the Jmjc-domain lysine demethylase PHF8 was identified as a TOPBP1 ligand 
protein, with a casein kinase 2 (CK2)-phosphorylated motif at Ser 854 in PHF8, apparently 
binding to the canonical BRCT7,8 module of TOPBP1 [67]. However, this is called into 
question by recent data [68] that structurally characterises an unusual phosphorylation-
independent interaction of the region around Ser 854 with BRCT7,8 and suggests a role for 
PHF8 in facilitating TOPBP1 interactions through targeted demethylation of Lys118 within 
the PB-motif of BRCT1. Clearly further work will be required to fully delineate the role of 
PHF8 in the complex functions of TOPBP1. 
Although not an enzyme itself, but rather a regulator of one - the protein phosphatase PP2A 
inhibitor CIP2A has recently been characterised as an essential TOPBP1 interactor [69, 70]. 
CIP2A appears to primarily interact with a region of TOPBP1 between BRCT5 and BRCT6, 
but whether its interaction is dependent on phosphorylation is unclear. The two studies make 
different conclusions about the function of CIP2A in TOPBP1 biology, with one [69] showing 
a particular involvement in the repair of DNA double-strand breaks occurring during mitosis, 
while the other [70] suggesting a more general role in dampening DNA damage checkpoint 
signalling. In any event, CIP2A appears to be an essential factor for the roles of TOPBP1 in 
maintaining genomic stability, but more work will be required to understand the biochemical 
mechanism by which this is accomplished. 
A direct interaction between BRCT6 of TOPBP1 and the transcription factor E2F1 has been 
identified [71] although the apparent requirement for phosphorylation [72], despite lack of the 
PB-motif phosphorylation coordinating residues in BRCT6 [66], would suggest a unique, and 












3.2 Scaffold crosstalk 
The greatest level of complexity in the assembly of DNA damage response complexes, 
arises from the phosphorylation-dependent interaction of many of the large scaffold proteins 
with themselves and each other, generating the extensive linked protein networks that most 
likely underpin the architecture of the macromolecular assemblies that become visible as 
DNA damage foci. 
TOPBP1 has been shown to associate with all three of the main DDR scaffolds that possess 
C-terminal BRCT2 modules, BRCA1, 53BP1, MDC1 [73-75]. Of these, the interaction with 
BRCA1 is the least well characterised, with no direct biochemical interaction having been 
demonstrated. As both TOPBP1 and BRCA1 interact with FANCJ/BACH1 [76] in a 
phosphorylation-dependent manner, it is possible that their interaction is indirect, but 
nonetheless intimate. 
In contrast, the interaction of TOPBP1 and 53BP1 is direct and involves simultaneous 
binding of two phosphorylated 53BP1 motifs centred at Ser 366 and Thr 670 with TOPBP1-
BRCT5 and BRCT2 respectively [77], and disruption of these interactions in cells generates 
a defect in the G1/S checkpoint response. Although the sites contain SP and TP motifs that 
are often targets of cell-cycle regulatory cyclin-dependent kinases (CDKs), their formation is 
DNA damage dependent and resistant to CDK inhibitors. The kinase (or kinases) 
responsible remain unknown. A more complex interaction occurs between the S.pombe 
orthologues of TOPBP1 and 53BP1, Rad4 and Crb2 [78] and is critical for an effective DNA 
damage response. In this system two canonical CDK phosphorylation sites in Crb2, Thr215 
and Thr235, recruit Rad4 through their cooperative interaction with BRCT1 and BRCT2 
respectively. This then facilitates phosphorylation of a non-canonical site at Thr187 by the 
cyclin-dependent kinase Cdc2-Cdc13 which associates with Rad4 via a phosphorylation-
independent interaction with the BRCT3,4 module. A single Rad4 molecule then bridges the 
resulting two phosphorylated Thr187 residues of a Crb2 dimer through their high-affinity 
interaction with BRCT1 and BRCT2 [59]. 
Association of MDC1 with TOPBP1 was initially identified as a functionally important 
contributor to recruitment of TOPBP1 to stalled replication forks and ATR-dependent 
activation of CHK1 [75]. This association was attributed to interaction of the highly 
phosphorylated pSDT repeats of MDC1 with BRCT4,5, and was supported by a crystal 











this motif was unusual, and in contrast to that observed for BRCT4,5 binding to 
phosphopeptides from 53BP1 and BLM [63, 77], as it did not involve the phosphate on the 
phosphorylated serine making the expected set of interactions with the conserved PB-motif. 
Surprisingly, despite strong conservation on both sides, no interaction was observed 
between the single SDT motif present in Mdb1, the S.pombe homologue of MDC1, and any 
part of Rad4, the S.pombe homologue of TOPBP1. Instead, a high-affinity interaction was 
found between a known CDK phosphorylation site at Thr113 [79] and BRCT2 of Rad4 [80]. 
A subsequent analysis of human MDC1 showed no interaction in vitro between any of the six 
pSDT motifs and TOPBP1 in contradiction to [75], but instead identified two CK2 
phosphorylation sites at Ser168 and Ser196, which mediated a functionally significant 
interaction of MDC1 and TOPBP1 required for survival of DSBs in mitotic cells through the 
formation of inter-chromosomal bridges [81]. 
Treacle/TCOF1 is a component of a large ribonuclear protein complex located in the 
nucleolus, that plays a role in regulating ribosomal RNA transcription in response to DNA 
damage [82, 83]. Its low level of sequence complexity, lack of identifiable globular regions 
and high level of posttranslational modification implicate it as a scaffold protein. Like MDC1, 
treacle/TCOF1 has a repeated array of phosphorylated Ser-x-Thr motifs, which also interact 
with the FHA domain of NBS1. Treacle/TCOF1 also interacts with TOPBP1 through a cluster 
of phosphorylation sites that appear to interact with both of the BRCT0,1,2 and BRCT4,5 
modules [84], however which phosphorylated residues interact with which BRCT domain has 
not yet been determined. Recruitment of TOPBP1 by Treacle/TCOF1 facilitates activation of 
ATR signalling which is required for the nucleolar response to DNA damage. 
Several studies have suggested that TOPBP1, like its scaffold partners 53BP1 and MDC1 
[85, 86], functions in an oligomeric or at least dimeric state in some of its roles [81, 87-89]. 
TOPBP1 certainly forms distinct nuclear foci following DNA damage [77] and recent studies 
suggest that these may be substantial condensates [90]. However, the formation and 
distribution of these focal condensates can be very substantially altered by single point 
mutations in TOPBP1 or in its interacting partner proteins. This suggests that these nano-
scale TOPBP1 assemblies result from extensive cross-linked networks of highly specific 
protein-protein interactions, rather than gross chemical properties of the molecules involved, 
as would be the case in bona fide liquid phase separations. Detailed structural studies will be 













3.3 Assembling Replication Complexes 
TOPBP1, Dpb11 and Rad4, play key roles in the assembly of the replicative DNA helicase 
CMG complex and its specific loading at replication origins, through their phosphorylation-
dependent interaction with the assembly factors Sld3 and Sld2/Drc1 in budding and fission 
yeast, and their functional equivalents treslin and RECQL4 in animal cells [91-94]. Like the 
interaction of Crb2 with Rad4 [59], interaction of Sld3/treslin involves simultaneous binding of 
a pair of CDK-phosphorylated sites on the assembly factor, to the BRCT1,2 module of 
TOPBP1/Rad4/Dpb11 [80]. 
TOPBP1 BRCT0,1,2, along with BRCT6, have also been shown to interact directly with 
CDC45 as part of replication initiation [95], although no specific phosphorylation sites on 
CDC45, or the requirement for phosphorylation, have yet been identified for this interaction. 
Similarly, the yeast ortholog Dpb11 interacts directly with Cdc45 [96]. 
The yeast Sld2/Drc1 proteins interact with the BRCT3,4 module of Dpb11/Rad4 via a single 
CDK phosphorylation site in the N-terminal end of the assembly factor [97], so that Sld2 and 
Sld3, and their respective binding partners GINS-Polε and Cdc45 are brought together 
through simultaneous interaction with the same TOPBP1/Rad4/Dpb11 molecule (but see 
below). Although no mammalian Sld2 homologue has been identified, the RECQ-family 
helicase RECQL4 has been suggested to fulfil a similar role through its involvement in DNA 
replication initiation, and the presence of an N-terminal domain with some homology to the 
N-terminal region of Sld2 implicated in interaction with Dpb11/Rad4 [98]. However, the CDK 
phosphorylation site that is highly conserved in the yeast proteins is absent from RECQL4, 
and interaction studies suggest that the N-terminal region of RECQL4 binds in a 
phosphorylation-independent manner to a C-terminal segment of TOPBP1 including the 
BRCT7,8 module and an upstream proline-rich region [99].  
 
3.4 Assembling Checkpoint Signalling Complexes 
Perhaps the best described role of TOPBP1, conserved across Dpb11/Rad4, is as the 
bridge between the RAD9-RAD1-HUS1 (9-1-1) clamp, and ATR-ATRIP bound via RPA to 
segments of ssDNA [100-102]. While the interaction with ATR is mediated by a 
predominantly unstructured ATR-activating domain (AAD) near the C-terminus of 
TOPBP1/Dpb11/Rad4 [103-105], the link to 9-1-1 is mediated by binding of the 
phosphorylated C-terminus of RAD9/Ddc1/Rad9 [101, 106, 107] to one or other of the 











1 is constitutive and performed by CK2 [108] binding is highly specific for TOPBP1-BRCT1 
[58, 80], whereas in S.pombe, where the C-terminal phosphorylation of the Rad9 tail is DNA-
damage dependent [109], the interaction is with Rad4-BRCT4 [59]. 
In animals, the interaction of 9-1-1 and TOPBP1 can also be bridged independently of RAD9 
phosphorylation, by RHNO1 [110], a largely unstructured protein that binds to the edge of 
the 9-1-1 ring via a region in its N-terminus [111], and to TOPBP1 via a conserved 
phosphorylation site in its C-terminus – Thr202 – which binds specifically to BRCT1 of 
TOPBP1 with high affinity [80]. The considerably higher affinity for BRCT1 of RHNO1 
compared to RAD9 suggests that the former is likely to be the predominant ligand for this 
site, in a 9-1-1 – RHNO1 – TOPBP1 complex [112]. However, if TOPBP1 does self-
associate as has been suggested [89] RHNO1 and RAD9 could cooperate in linking a 
TOPBP1 dimer to a single DNA-bound 9-1-1 clamp. 
 
 
3.5 Specificity of TOPBP1 BRCT domains 
The structural and biochemical characterisation of a number of TOPBP1/Rad4 complexes 
with ligand proteins, provides insight into the sequence specificity of the phosphorylation-
dependent interactions made by the competent BRCT domains [80]. Phospho-threonines 
are the predominant modified residue in binding motifs for both domains, but phospho-
serine, as in RAD9-pSer387 and treslin-pSer1001, is certainly not ruled out. Both BRCT1 
and BRCT2 display a strong requirement for a small/medium hydrophobic residue -3 relative 
to the phosphorylated residue, and Asp/Glu is common in the -1 position for both (FIGURE 
3D). Proline is also common at the +1 position, but the peptide side-chain makes no direct 
contacts, and its presence is more to do with the specificity requirements of the kinase – 
often a CDK – that is responsible for the phosphorylation of the motif, rather than its 
interaction with the BRCT domains. The major distinction in binding preference comes from 
the presence of a large hydrophobic pocket in BRCT1 that allows binding of two consecutive 
hydrophobic residues (-2, -3), with a third (-4) folding back against the backbone of the 
ligand peptide, stabilising a kinked conformation (FIGURE 4A). In BRCT2, this pocket can 
only accommodate the -1 hydrophobic residue, so that the peptide binds in an extended β-
sheet conformation that permits a hydrophilic residue at -2 (FIGURE 4B). Thus, the main 
selectivity between BRCT1 and BRCT2 results from motifs with hydrophilic residues at -2 











(-2, -3, -4) that bind BRCT1 (e.g. Crb2-pThr 187), may also be able to bind to BRCT2, but do 
so with a different conformation (FIGURE 4C and 4D). 
Only two bona fide ligand complexes for the second phospho-binding BRCT module 
TOPBP1-BRCT4,5 (3,4 in Rad4/Dpb11) have been structurally characterised [63, 77]. These 
both show a very similar binding conformation for the ligand motif as in BRCT2, with 
residues -4 to +1 in an extended β-sheet conformation, dictated by a comparably small 
hydrophobic pocket accommodating the hydrophobic side-chain of the -3 residue. 
Comparison of these with biochemically identified binding motifs for Rad4/Dpb11 from 
S.pombe Rad9 and S.cerevisiae Sld2 (FIGURE 3D), reveals an additional strong preference 
for a proline residue at -1. In both BLM-pS304 and 53BP1-pS366 complexes with TOPBP1-
BRCT4,5, this proline forms a key part of a hydrophobic sandwich, which, along with the 
main chain of the -2 and -3 residues, and the side chain of the -4 residue, surrounds the 
protruding side chain of TOPBP1-Tyr678 (FIGURE 4E and 4F). 
The only phosphorylation-dependent ligand interaction so far characterised for the  BRCT7,8 
module, which is absent from the yeast TOPBP1-homologues, is with FANCJ/BACH1 [55, 
56] (FIGURE 3D), and is very similar to complexes of other phosphorylated motifs to BRCT2 
modules (FIGURE 4G), although it displays a substantial induced-fit mechanism not evident 
in other BRCT2 modules. Although not phosphorylation dependent, the recently reported 
interaction of PHF8 involves the same face of BRCT7,8 [68] (see text above and FIGURE 
4H) and would be competitive with binding of phosphorylated ligands to that site. 
 
3.6 Combinatorial Complexity 
The multiple binding sites for different ligands that TOPBP1 provides, underlies its function 
as a scaffold protein, mediating and reinforcing the co-localisation of proteins that may have 
little inherent affinity for each other, but can collaborate and co-operate through their 
association with a common binding partner. Central to this is the phosphorylation 
independent interaction of the PI3-kinase-like kinase ATR, with the ATR Activating Domain 
(AAD) of TOPBP1/Rad4/Dpb11, which is necessary for the activation of ATR signalling [103-
105], and appears to be the unique function of this conserved region of 
TOPBP1/Rad4/Dpb11. Interactions with other ligands via the more promiscuous BRCT 
domains, then provides a model for coupling ATR activation to whatever DNA context is 
dictated by any other ligand or ligands bound simultaneously to the same TOPBP1 











TOPBP1 roles in DNA damage signalling, the AAD seems to be dispensable for its role in 
CMG assembly [93]. 
 
4. Conclusion 
All the multi-BRCT modules of TOPBP1 have been implicated in binding to multiple ligands, 
and although no direct ligands of BRCT0 or the singleton BRCT domains 3 and 6 have yet 
been definitively identified, there is no reason to assume that these will be different. This 
raises the possibility of a substantial number of different TOPBP1-based complexes that 
could exist, incorporating different combinations of ligands bound to the different attachment 
points the scaffold provides. If as has been suggested, TOPBP1 molecules self-associate 
into dimers or even oligomers [81, 87-89], then we are presented at least in principle, with a 
huge combinatorial tangle in which TOPBP1 and all its ligands might be simultaneously 
present. This may be modulated by different phosphorylation-dependent ligands only 
associating with TOPBP1 at defined cell cycle stages e.g. treslin in S-phase [113] and MDC1 
in mitosis [81], or in defined nuclear locations e.g. Treacle/TCOF1 in nucleoli, or following 
specific signalling events e.g. 53BP1 following DNA damage in G1 [74, 77], but the potential 
complexity of multi-ligand complexes remains substantial and has been only lightly 
investigated. 
Simultaneous interaction of two phosphorylation-dependant ligands has been inferred 
genetically in S.cerevisiae for Sld2 and Sld3 binding to Dpb11 [114], and demonstrated 
directly for the Ddc1 component of yeast 9-1-1 (Ddc1-Mec3-Rad17) and Fun30 binding to 
Dpb11 [61], and for binding of RAD9 in 9-1-1 and 53BP1 to TOPBP1 [77]. In all three cases, 
the binding sites for the two ligands are fully compatible with simultaneous binding to a 
single TOPBP1 molecule. Thus, Sdl2 and Ddc1 bind to the BRCT4 module while their 
respective partners in a ternary complex with Dpb11, Sld3 and Fun30, bind to the BRCT1,2 
module. Similarly, RAD9 in human 9-1-1 binds to BRCT1 of TOPBP1, while 53BP1 engages 
in parallel with BRCT2 and BRCT5. Although not yet experimentally confirmed, the likely 
interaction of the metazoan homologue of Fun30, SMARCAD1, with BRCT2, would allow a 
similar co-operation with 9-1-1 (FIGURE 5). By contrast, the apparent simultaneous 
engagement of RAD9 and RHNO1 [89], which both bind selectively to BRCT1 of TOPBP1 
[80], can only be explained by interaction with separate TOPBP1 molecules within an 











Since its discovery a quarter of a century ago, TOPBP1 has become one of the central 
players in genome stability through its pleotropic involvement in DNA replication, damage 
signalling and repair, but how these different functions interrelate and how they are 
sustained and reconciled by a single protein, is very poorly understood. Future studies 
addressing the temporal and spatial distribution of the many complexes TOPBP1 
orchestrates, as well as their composition and three-dimensional structure, will provide new 
insights into this fascinating scaffold protein. 
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FIGURE LEGENDS 
Figure 1 – Phosphopeptide bound structures of the γH2AX or γH2A C-terminal BRCT2 
modules. BRCT domain secondary structure cartoons are rainbow-coloured (N-terminus 
blue - > C terminus red), the histone tail peptides shown as white sticks, and with dashed 
magenta lines indicating hydrogen bonding interactions between the chains. 
A. MDC1 (PDB: 2AZM) [8] the phosphate of γH2AX peptide is coordinated by Thr-1898 
and Lys-1936 of MDC1 with the carboxyl-terminus of the peptide recognised by Arg-
1933. 
B. Mdb1 (PDB: 7P0L) (unpublished data) shows a similar arrangement as for the 
human ortholog with Ser-392 and Lys-434 and Arg-431 taking the role of previously 
labelled residues. 
C. Crb2 (PDB: 2VXC) [16] as described in the text. 
D. 53BP1 (PDB: 5ECG) [11] Thr-1737, Lys-1773 and Lys-1814 forming the PB-motif 
triplet and Arg-1811 interacting with the carboxyl-terminus of the peptide. 
E. PTIP (PDB: 3SQD) [20] Similarly to MDC1 there is no coordinating residue in the 
Arginine position of the PB-motif triplet but the other two residues Thr-872 and Lys-












F. MCPH1 (PDB: 3SZM) [24] Thr653 and Asn-696 take the two crucial phosphate 
coordinating positions and the carboxylate of Tyr-143 is picked up by Arg-693 and in 
this case an additional H-bond to Lys-814. 
G. MCPH1 bound to H2AX pS139 pY142 peptide (PDB: 3U3Z) [25] Ser-769 in the 
BRCT domain forms a H-bond with the phosphate group of pTyr-142, while the 
sidechain of H2AX Gln-140 is altered to accommodate the phosphate, but the 
positioning is overwise very similar to that of the singly phosphorylated peptide 
structure. 
H. BRCA1 bound to FANCJ/BACH1 pS990 (PDB: 1T15) [34] with the phosphorylation 
picked up by Ser-1655 and Lys-1702 in the BRCT domain. Arg-1699 sits in the 
equivalent location of the carboxyl coordinating arginine in the histone tail binders, 
but in this case it picks up a H-bond to the mainchain carbonyl of the residue in the 
+3 position. 
 
Figure 2 – PB-motifs in PTIP, Brc1 and Rtt107 BRCT domains.  
A. Structure based alignment of PTIP, Brc1 and Rtt107 BRCT domain pairs, including 
RAD4 BRCTs 1 and 2 as both have PB motif, using PROMALS3D Webserver. 
Helices coloured red, strands in blue, and PB-motif residues are marked with an 
asterix. PB-motifs can be seen in PTIP BRCTs 2, 4 and 5, Brc1 BRCTs 4 and 5 and 
Rtt107 BRCTs 4 and 5. 
B. BRCT domain secondary structure cartoon representation of BRCTs 1-4 of Rtt107 
(PDB 6J0V) rainbow-coloured (N-terminus blue - > C terminus red), with the PB-motif 
residues highlighted as magenta sticks, and the surface represented showing the 
groove on the surface. 
C. Nse6 bound structure of Rtt107 (PDB 6J0W) showing the proximity of Serine-18 in 
Nse6 to the phosphate binding site in BRCT 4 of Rtt107. The Nse6 peptide is shown 
as white sticks and labelled with white lettering on black background. 
 
Figure 3 – Mapped interactions of TOPBP1, Rad4 and Dpb11. Phosphorylation 












A. Schematic representation of human TOPBP1 showing interactions with RAD9 [58], 
MDC1 [81], RHNO1 [80], 53BP1 [77], SMARCAD1 [61], TRESLIN [80], GINS [115], 
BLM [63], CIP2A [116], PARP1 [65], E2F1 [71], CDC45 [95], FANCJ/BACH1 [55], 
PHF8 [68], RECQL4 [99], TOP2A [64], TOP2B [53]. 
B. Schematic representation of S.pombe Rad4 showing interactions with Mdb1 [80], 
Crb2 [59], Sld3 [94], Rad9 [109], Sld2 [94], Cdc2-Cdc13 [59]. 
C. Schematic representation of S.cerevisiae Rtt107 showing interactions with Rad9 
[117], Slx4 [118], Fun30 [61], Sld3 [92], Ddc1 [118], Sld2 [97]. 
D. Alignment of experimentally determined phosphorylated motifs binding to different 
BRCT domains of TOPBP1. The residue number indicates the phosphorylated 
residue. The key specificity determinants for binding to each site are highlighted. 
 
Figure 4 - Peptide bound structures of the BRCT modules of TOPBP1. BRCT domain 
secondary structure cartoons are rainbow-coloured (N-terminus blue - > C terminus red), the 
various peptides shown as white sticks, and with dashed magenta lines indicating hydrogen 
bonding interactions between the chains. Structural determinants of specificity are described 
in the text. 
A. RAD9 pS387 bound to BRCT 1 (PDB: 6HM5) [80]. 
B. 53BP1 pT670 bound to BRCT 2 (PDB: 6RML) [77]. 
C. Crb2 pT187 bound to BRCT 1 of Rad4 BRCTs 12 (PDB: 4BU0) [59]. 
D. Crb2 pT187 bound to BRCT 2 of Rad4 BRCTs 12 (PDB: 4BU1) [59]. 
E. 53BP1 pS366 bound to BRCTs 45 (PDB: 6RMM) [77]. 
F. BLM pS304 bound to BRCTs 45 of mouse TOPBP1 (PDB: 5U6K) [63]. 
G. FANCJ/BACH1 pT1133 bound to BRCTs 78 (PDB: 3AL3) [55]. 
H. PHF8 bound to BRCTs 78 (PDB: 7CMZ) [68]. 
Figure 5 – TOPBP1 multiprotein complexes. Schematics of experimentally determined 












A. 53BP1 interacts with BRCT domains 2 and 5 while RAD9 the component of 9-1-1 
interacts with BRCT1. 
B. Sld3 binds BRCT domains 1 and 2 of Dpb11, while Sld2 binds BRCT4. A similar 
arrangement is likely in S.pombe. 
C. Fun30 binds BRCT domain 2 of Dpb11, while the Ddc1 component of the 
S.cerevisiae 9-1-1 complex binds BRCT4. In the equivalent metazoan arrangement, 
SMARCAD1 – the homologue of Fun30 – also interacts with BRCT2, whereas the 
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